|
answer text |
<p>The Government’s Five Year Antimicrobial Resistance (AMR) Strategy 2013-18 recognised
the importance of making better use of existing and new rapid diagnostics to optimise
the use of antimicrobials.</p><p> </p><p>NHS England leads a programme of work to
ensure that we have patient focused diagnostics that support clinical decision making
and delivery of the Government’s ambitions on AMR. A new United Kingdom AMR diagnostic
collaborative, led by NHS England, aims to provide clarity about which tests should
be undertaken and in which setting.</p><p> </p><p>The National Institute for Health
and Care Excellence is developing a series of short syndrome-specific clinical guidelines
to support clinicians to diagnose and treat common infections utilising the latest
data and evidence.</p><p> </p><p>In the last five years the UK has seen unprecedented
research collaboration and investment aimed at tackling AMR nationally and internationally;
diagnostics continue to be a priority theme for research.</p>
|
|